Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513773 · ClinicalTrials.gov registry record
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
A clinical trial of Aortic Aneurysm, Abdominal, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT00513773: Completed study of Aortic Aneurysm, Abdominal, sponsored by Vanderbilt University Medical Center.
NCT00513773 is a study of Aortic Aneurysm, Abdominal that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 14 participants, below the 153-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00513773, a study of Aortic Aneurysm, Abdominal, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand the role of inflammation in the pathophysiology of abdominal aortic aneurysm. In this study we hope to show better ways of predicting risk in this condition by using a combination of FDG-PET with CT.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-07 |
| Est. Completion | 2014-02 |
What the finished NCT00513773 record still lists
NCT00513773 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 153-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Aortic Aneurysm, Abdominal appearing as the primary indexed condition, and to 0 interventions.
NCT00513773 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00513773 about?
NCT00513773 is a clinical study titled "Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm". The purpose of this study is to better understand the role of inflammation in the pathophysiology of abdominal aortic aneurysm. In this study we hope to show better ways of predicting risk in this condition by using a combination of FDG-PET with CT.
What is the current status of trial NCT00513773?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-07. Estimated completion is 2014-02.
What conditions does trial NCT00513773 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Abdominal.
Who is sponsoring clinical trial NCT00513773?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00513773 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Abdominal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00513773's enrollment target sits among peer trials
14 8th of 8 the lowest of 8 other Aortic Aneurysm, Abdominal trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Aneurysm, Abdominal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
RECRUITING · NA
-
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
RECRUITING · NA
-
Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms
RECRUITING
-
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
RECRUITING · NA
-
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
RECRUITING · Phase 4
-
Zenith® Fenestrated+ Clinical Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia